Life Science Analytics (LSA)

Overview

Life Science Analytics is a biomedical data company that provides corporate intelligence and research products to life science companies and financial industry professionals. Business development officers, librarians and executives of biomedical companies, as well as vendors and consultants who serve those companies, turn to LSA for their corporate intelligence projects.

Note: LSA reports are prepared by Life Science Analytics (LSA) analysts using data from MedTRACK, a proven competitive intelligence source for the life sciences.

Our Products

Financial Reports
These reports contain the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market related data including relative strength, valuation and revenues.

Each report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally each report includes quarterly book value per share vs. share price. Much of the information contained in each report is included in both tabular and graphic formats.

Product Pipeline Reports
Each report contains: Business Summary; Contact Information; Selected Financial Data; Company Details; Product Glance (Table/Graph); Disease Hub Classification (Table/Graph); Product Pipeline; Product Catalog; Product Details with Description; Therapeutic Indication; Drug Class; Mechanism of Action; Current Trial; Trial Details; Partnering Details etc; Patent Details (if any); Recent Financings; Trademarks; Deals & Alliances; Management Profile; Recent Updates

Competitor Reports
These report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. Each report also includes recent company news updates

Deals & Alliances Reports
Each report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category (product, technology, miscellaneous), stage of development, list of partners, deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner firm where disclosed, partners in other non-product, non-technology deals, with detailed descriptions of the partner firm and terms when available. Each report also includes M&A statistics and recent partnering news updates by date.

Life Science Analytics (LSA)
 

List of reports from Life Science Analytics (LSA)

5  6  7  8    10    12  13  14  
Callisto Pharmaceuticals Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Cortex Pharmaceuticals Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Caraco Pharmaceutical Laboratories Ltd-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  read more...
$350.00
CPEX Pharmaceuticals, Inc.-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
CorMedix Inc.-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
Champions Biotechnology, Inc.-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Cellceutix Corporation-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
Neuralstem Inc.-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
CardioVascular BioTherapeutics Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
CEL-SCI Corporation-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
Cardium Therapeutics Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Cyanotech Corporation-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
Cytokinetics Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
DARA BioSciences, Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Depomed Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
Derma Sciences Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Dynavax Technologies Corp-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Emergent BioSolutions Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Emisphere Technologies Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Endo Pharmaceuticals Holdings Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  read more...
$350.00
Enzon Pharmaceuticals Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Flamel Technologies SA ADS-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  read more...
$350.00
Gentium S.p.A-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
Global Health Ventures, Inc.-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  read more...
$350.00
Genta Incorporated-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
5  6  7  8    10    12  13  14  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!